Applied DNA Sciences Inc
APDN5.620USD
0.000
Close 12/24, 13:00（ET）Quotes delayed by 15 min
5.07MMarket Cap
LossP/E TTM
Applied DNA Sciences Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
2.14M
-37.72%
EPS(YoY)
-134.23
90.18%
Analyst Rating
2025-09-28
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its total revenue reached 2.14M, with a year-on-year change of -37.72%.
What is the Earnings Per Share (EPS) of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -134.231, with a year-on-year change of 90.18%.
What is the net income of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its net income was -69.49M, with a year-on-year change of -861.69%.
What is the net margin of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its net profit margin was -699.90%, with a year-on-year change of -238.82%.
What is the gross margin of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its gross margin was 39.26%, with a year-on-year change of 32.47%.
What is the debt-to-asset ratio of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -1207.18%, with a year-on-year change of -1077.32%.
What is the Return on Assets (ROA) of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -173.65%, with a year-on-year change of -223.86%.
What is the operating profit of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its operating profit was -16.05M, with a year-on-year change of -14.42%.
What are the current assets of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its current assets were 2.24M, with a year-on-year change of -72.19%.
What are the total assets of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its total assets of Applied DNA Sciences Inc were 4.44M, with a year-on-year change of -65.30%.
What are the total liabilities of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its total liabilities of Applied DNA Sciences Inc were 2.50M, with a year-on-year change of -34.68%.
What is the total equity of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its total equity of Applied DNA Sciences Inc was 1.94M, with a year-on-year change of -78.35%.
What is the net operating income of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its net operating income of Applied DNA Sciences Inc was -15.35M, with a year-on-year change of -116.54%.
What is the net investment of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its net investment of Applied DNA Sciences Inc was -313.12K, with a year-on-year change of 23.24%.
What is the net financing of Applied DNA Sciences Inc?
According to Applied DNA Sciences Inc's FY2025 earnings report, its net financing of Applied DNA Sciences Inc was 8.05M, with a year-on-year change of -39.89%.
